Aultman Hospital cancer experts believe research is the cornerstone of good clinical practice. We partner with national research organizations to offer innovative treatments, affiliated with research entities including the Eastern Cooperative Oncology Group (ECOG-ACRIN), the National Surgical Adjuvant Breast and Bowel Project, the Gynecologic Oncology Group, Radiation Therapy Oncology Group (NRG) and the Cancer Trials Support Unit. All of these organizations are sanctioned by the National Cancer Institute and the National Institutes of Health. We also collaborate with select pharmaceutical companies to offer cutting edge treatments to establish new standards of care.

Clinical trials evaluate the effectiveness of completely new approaches to cancer treatment and of existing therapies used in new ways. By evaluating the results of clinical trials, researchers discover better ways to treat and prevent cancer. The more people who participate in clinical trials, the faster medical science can answer critical questions about the origins and mechanisms of cancer.

Since its inception in 1983, the Aultman Cancer Center has accrued nearly 2,500 enrollees in more than 350 clinical trials devoted to the study and treatment of cancer. At this time, our clinical investigators - all board-certified physician specialist assisted by certified research coordinators and registered oncology nurses - are engaged in more than 50 oncology studies involving major disease sites and various disease phases.

Learn More
For additional information on cancer clinical trials at Aultman, please call 330-363-1250.